| Q37052726 | Advances in the treatments of systemic vasculitides |
| Q40919365 | Anti-endothelial cell auto-antibodies in hepatitis C virus mixed cryoglobulinemia |
| Q34504768 | Antibodies and vascular involvement in inflammatory joint disease: clinical relevance |
| Q42980242 | Anti‐HCV and HCV‐RNA prevalence and clinical correlations in cases with non‐Hodgkin's lymphoma |
| Q40711044 | Arterial thrombosis in the context of HCV-associated vascular disease can be prevented by protein C. |
| Q45983004 | Ascites in hepatitis C liver transplant recipients frequently occurs in the absence of advanced fibrosis. |
| Q34083182 | Association between chronic viral hepatitis infection and breast cancer risk: a nationwide population-based case-control study |
| Q34936701 | Autoimmunity and viruses |
| Q41115162 | Autoimmunity in hepatitis C and D virus infection |
| Q40721395 | Clinical and morphologic spectrum of renal involvement in patients with HBV-associated cryoglobulinaemia |
| Q59350954 | Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis |
| Q40890448 | Clinicopathological features of cryoglobulinemic glomerulonephritis associated with HBV infection: a retrospective analysis of 8 cases in China |
| Q45553745 | Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection |
| Q33811619 | Cryoglobulinemia |
| Q74514123 | Cryoglobulinemia due to chronic viral hepatitis infections is not a major problem in clinical practice |
| Q43037754 | Dendritic cell susceptibility to hepatitis C virus genotype 1 infection |
| Q44990800 | Effect of 51p1-related gene copy number (V1-69 locus) on production of hepatitis C-associated cryoglobulins |
| Q57004493 | Enhanced monocyte Th1 cytokine production in HCV-infected cryoglobulinemic patients |
| Q43041488 | Expression of hepatitis C virus core protein associated with malignant lymphoma in transgenic mice |
| Q33715911 | Extrahepatic manifestations of HCV infection: facts and controversies |
| Q45746740 | Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. |
| Q43479532 | Hepatitis C virus and autoimmunity: Fortuitous association or reality? |
| Q42998654 | Hepatitis C virus in non-Hodgkin's lymphoma. A reappraisal after a prospective case-control study of 300 patients. Lombart Study Group of HCV-Lymphoma |
| Q35445569 | Hepatitis C virus induced endothelial inflammatory response depends on the functional expression of TNFα receptor subtype 2 |
| Q41377154 | Hepatitis C virus infection and autoimmunity |
| Q42991127 | Hepatitis C virus infection and cryoglobulinemia |
| Q45742402 | Hepatitis C virus infection and lymphoproliferative diseases in France: a national study. The GERMIVIC Group |
| Q42980534 | Hepatitis C virus infection and mixed cryoglobulinaemia: assessment of HCV RNA copy numbers in supernatant, cryoprecipitate and non-liver cells |
| Q41669589 | Hepatitis C virus, autoimmunity and rheumatic disease |
| Q36081089 | Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations |
| Q37288114 | Hepatitis C virus, cryoglobulinemia, and kidney: novel evidence |
| Q33363781 | Hepatitis C virus-associated extrahepatic manifestations: a review |
| Q34098553 | Hepatitis C virus-related lymphoproliferative disorders: an overview. |
| Q74600350 | Hepatitis C-associated autoimmune disorders |
| Q58621898 | Increased soluble p55 and p75 tumour necrosis factor-alpha receptors in patients with hepatitis C-associated mixed cryoglobulinaemia |
| Q45735396 | Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia |
| Q43039778 | Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis |
| Q42996104 | Mixed cryoglobulinaemia in patients with chronic hepatitis C infection: prevalence, significance and relationship with different viral genotypes |
| Q36971072 | Mixed cryoglobulinemia: a model of virus-related disease in internal medicine |
| Q33901848 | Mixed cryoglobulinemia: new concepts |
| Q40836416 | Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients |
| Q42980554 | Myasthenia gravis and hepatitis C virus infection |
| Q45754354 | No evidence for abnormal immune activation in peripheral blood T cells in patients with hepatitis C virus (HCV) infection with or without cryoglobulinaemia. Multivirc Group |
| Q47752721 | Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia. |
| Q41771952 | Parvovirus B19 infection, hepatitis C virus infection, and mixed cryoglobulinaemia |
| Q43854465 | Peripheral neuropathy and hepatitis C virus infection: more than cryoglobulinemia |
| Q33735350 | Peripheral neuropathy associated with essential mixed cryoglobulinaemia: a role for hepatitis C virus infection? |
| Q27487761 | Persisting Mixed Cryoglobulinemia in Chikungunya Infection |
| Q45786212 | Posttransfusional, LKM-1-autoantibody-positive hepatitis C virus infection, cryoglobulinemia, and aplastic anemia |
| Q38997365 | Prevalence and clinical significance of circulating cryoglobulins in HIV-positive patients with and without co-infection with hepatitis C virus |
| Q42982045 | Prevalence of hepatitis B and C viruses in patients with lymphoproliferative disorders |
| Q42236858 | Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders in Southern Turkey |
| Q27477841 | Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort |
| Q45368252 | Prognostic factors in patients with hepatitis C virus infection and systemic vasculitis. |
| Q27480975 | Quantitative measurement of hepatitis C virus core antigen is affected by the presence of cryoglobulins |
| Q40374984 | Quantitative molecular methods in virology |
| Q40591268 | Renal manifestations of hepatitis C virus infection |
| Q41877545 | Resolution of neurological deficits secondary to spontaneous intracranial haemorrhage and posterior reversible encephalopathy syndrome (PRES) in a patient with hepatitis C-associated cryoglobulinaemia: a role for plasmapheresis |
| Q35741844 | Spectrum and Prognosis of Noninfectious Renal Mixed Cryoglobulinemic GN. |
| Q42990955 | Stroke and limb ischaemia in hepatitis C virus-related cryoglobulinaemia |
| Q45759948 | Symmetric polyarthritis with livedo reticularis: a newly recognized manifestation of hepatitis C virus infection |
| Q34308860 | The cryoglobulins: an overview |
| Q41574278 | The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection |
| Q78171271 | The lady with a history of blood transfusion who developed palpable purpura and microhaematuria |
| Q39343958 | Treatment of hepatitis C cryoglobulinemia: mission and challenges |
| Q43738340 | Type II cryoglobulinemia is not associated with hepatitis C infection: the Dutch experience |
| Q77524902 | [Role of neutralizing antibodies and cellular immunity in hepatitis C virus infection] |
| Q55241177 | [Sjögren's syndrome and virus]. |
| Q81189395 | [Vasculitis associated with viral infections] |